Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: E_K_S who wrote (59017)	2/6/2017 6:29:10 PM
From: Spekulatius	1 Recommendation Recommended By Jurgis Bekepuris Read Replies (2) \| Respond to of 78741

I have been using the finviz screener, looking for stocks 0-10% above the 52 week lows and PE's <15. There are some stocks popping up, but not many, that I find interesting. Some sectors with stocks that look like value: Reits - under pressure from higher interest rates, especially B and C- mall owners, where there is signifiant secular decline risk Retail stocks - RL, GIL Pharma - NVO, GILD GIL is not really cheap and neither is RL. RL probably needs a significant restructuring. NVO is growth darling that has fallen from grace, but still trades at ~15x earning, which is think is fair, but not cheap. One could buy pharma stocks for <10x earnings for quite a long time, when the sector was growth challenged. I think we could get back to this level again, because the sector has been living off significant price increases during the last few years, which are not sustainable. GILD is cheap based on current earnings, but it looks like earnings are going to fall for a few years going forward. It is difficult to estimate the normalized earnings power, if there even is such a thing. I do think that the market seems to overemphasize the earnings pressures. GILD management team has shown in the past that they are quite astute - maybe they can pull another Hattrick and fatten their pipeline again.